Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2012-12-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A - Measurement of GHJ thickness at 3 points and average value calculation on body supine position and with arm supinated, maximal externally rotated with elbow angle 90 degrees
* By longitudinal access with transducer position laterally to coracoids along to the GHJ line, located as diagonal form lower to forward and lateral direction with demonstration the joint cartilage posteriorly and subscapular tendon anteriorly (Fig.4)
* By transversal access with 90 degrees to longitudinal and at 3 points: upper with coracoids visualization, middle and lower (Fig.5-7).
B - Measurement of rotator interval with assessment of width and higher.
2. Comparison of the data with results of classic values have been received by posterior and inferior (axillar) approach.
3. Comparison of the results between patients with Rheumatoid Arthritis (RA) and healthy controls
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantitative MRI of Glenohumeral Cartilage & Labrum in Shoulder Instability
NCT05431114
Glenohumeral Joint Contract Patterns in Osteoarthritic Glenoids
NCT06154694
Clinical and Radiologic Follow up of Subchondral Fractures of the Glenoid
NCT02308423
Evaluation of the Difference in the Acromion Humerus Gap at Sitting,Lying
NCT01264926
3D MR Versus 3D CT for Glenohumeral Arthritis
NCT03379545
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Materials and methods:
US will be performed for 20 healthy controls and 20 patients with RA. US scan will be fulfilled symmetric both sides. Diagnosis RA is relied on anamnesis data, physical examination, and laboratory findings. Synovial swelling, synovial tenderness, local fever of joint region, active and passive limitation, accelerated erythrocyte sedimentation rate(ESR) upper 40mm/hr (N\<12), C reactive protein (CRP) upper 1.5mg/dl (N\<0.5) were clinical signs of active inflammation. Twenty healthy controls did not complain of shoulder pain and limitation and their physical examination was unremarkable.
Study process:
US scan will be performed as prospective study for 20 healthy controls from department of preventive medicine and for 20 patients with RA age of 20-60 by to classic approaches: posterior and inferior and new anterior access. The last was accompanied by measurement of GHJ space and rotator interval in upper limb position of supination and external rotation. Comparison will be implemented between data of different positions and RA patients compared with controls.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rheumatoid Arthritis
20 patients age of 20-60 with Rheumatoid Arthritis according to ARA 1987 revised criteria and disease activity Disease Activity Score (DAS) 3-5
No interventions assigned to this group
Healthy controls participants
Healthy controls age of 20-60 according to conclusion of preventive medicine department
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with RA according to ARA 1987 revised criteria and disease activity DAS 3-5
Exclusion Criteria
2. Shoulder osteoarthritis
3. Rotator cuff disorders
4. Shoulder injections
5. Cervical spondylosis with nerve root compression, Cervical symptomatic disc syndromes
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Rozin, MD
Role: PRINCIPAL_INVESTIGATOR
Rambam Health Care Campus and Technion
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rheumatology unit
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0260-10CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.